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Experimental and Clinical Studies on Various Methods 
of Myocardial Protection-With Special Reference 
to Manni tol-Insulin-Potassium (MIK)-Solu tion 
KATSUHIKO MURATA 
The 2nd Department of Surgery, Faculty of Medicine, Kyoto Cniversity 
(Director: Prof. Dr. YORINORI HIKASA) 
In this paper, 9 model groups for myocardial protection in animal experiment;, were in 
spected from the aspect of myocardial energy metabolism (Energy Charge), cardiac function 
and ultrastructural evaluation. Nine groups were as follows: 
Group 1: Anoxic arrest without cooling. 
Group 2: Cardiac arrest by Young Solution without cooling. 
Group 3: Cardiac arrest by Young Solution plus coronary perfusion with GIK-Solution 
without cooling. 
Group 4・ Anoxicarrest with cooling (Myocard. Temp. 15°C). 
Group 5: Cardiac arrest by Young Solution with cooling (Myocard. Temp. 15°C). 
Group 6: Cardiac arrest by Young Solution plus coronary perfusion with GIK-Solution 
with cooling (Myocard. Temp. 15。C).
Group 7: Cardiac arrest by Young Solution plus coronary perfusion with Mannitol-
Insulin-Potassium (MIK)-Solution with cooling (:¥Iyocard. Temp. 15°C). 
Group 8: Cardiac arrest by Young Solution plus coronary perfusion with modified :¥IIK-
Solution containing of Mg++ and Ca++ with colling (Myocard. Temp. 15°C). 
Group 9: Cardiac arrest by Young Solution plus coronary perfusion with Mannitol-
Potassium (MK) Solution with cooling (Myocard. Temp. 15°C). 
Key~~示；可示示;;;Ip函示函~I示一一~n~示ーら·－－；；一一一~vith~cld;:~;diふム~ '¥lanm凶ーIn叫 in-
Potassium(MIKl-Solution, Modi五edl¥1IK-Solution. Glucose-Insulin-Potassium(GIK)-Solution. 
索引語：心筋保護，間歌的冷却冠獲流法， MIK－液， Modi五edMIK－液， GIKー液．Pres~~~ adres: The 2nd Department of Sur宮町， Facultyof ;¥I肝
606, Japan. 
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The absolute safe period of ischemia in animal experiments was 30 min. in Group 1, 60 min. 
in Group 2司 3,4, 120 min. in Group 5, 9 and 180 min. in Group 6, 7, 8. In the clinical studies, 
the methods of Group 6, 7, 8 were performed with excellent results. We could find no differences 
in these 3 methods from the point of myocardial energy metabolism and cardiac function in animal 
experiments, and observations of the myocardial ultrastructure, cardiac function, intra-and 




























Group 3：常温 Young氏液＋GIK500 ml/30分
Group 4：低温 AnoxicArrest群（心筋温 l5°C)
Group 5：低温 Young氏液使用群（心筋温 15°C)
Group 6：低温 Young氏液＋GIK500 rnl/30分（心筋温 15°C)
Group 7：低混 Young氏液＋i¥TIK 500 ml/30分（心筋温 15°C)
Group 8 .低温 Young氏液＋modi品edMIK 500 ml/30分（心筋温 15°C)
Group 9：低温 Young氏液＋MK500 ml/30分（心筋温 15°C)
GIK: Glucose-Insulin-Potassium solution 
5% glucose 500ml+K+ lOmEq+R.I IOU－トmeylon10 ml, 
pH 7.8, OSP 330 mOsm/L 
'.¥IK: Mannitol-Insulin-Potassit日nsolution 
5% mannitol 500rnJ+K+ lOmEq+R.I IOU十meylon10 ml, 
pH 7.8, OSP 330 mOsrn/L 
modi品edMIK 
:4% mannitol 500rnl+K+ 10rnEq+Mg++J6rnEq+Ca++J.4mEq十
R.I IOU +meylon 10 ml, pH 7.8, OSP 340 mOsm/L 
'.¥!K: i¥fannitol-Potassium solution 
5% mannitol 500 rnl+K+ 10 rnEq+rneylon 10 ml, 
pl I 7.8, OSP 330 mOsm/L 









酔剤は， thiopenthalsodium 25 mg/kgを静注し，気管



















ポンプを用いた． この際， Ht は30~ぢ以上， PA02 は





EC ・ー 一一・低温Young氏，直 (15C) 
。一一一o常温 Young氏液＋GIK500ml/30m1n 
・一一＿.低温Young氏液＋GIK500ml/30m1n(IS"C) 
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LIP・－ . fl!: •. 且 Young氏，壷使用・＿＿，低温 Young民濠＋GIK500ml/30分Cl5C)
・ー 一一・低温 Young民高＋MIK500ml/30分（15CI
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図3 大動脈遮断による心筋［L/P］比の変動
各種心筋保護法の実験的，臨床的検討
・ー』ーー・EC : An。則CA"est 。ーー -oL/P:An。xicArrest 
・一一一・EC :v。une氏液のみ。・一・。L/P:Young氏，盲のみ
・一ー ・ーEC Young氏濯＋GIK500ml/30m 
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かに低温群（第4，五， 6,7, 8, 9群），特lζヤング氏液























。ー 一ー一。 LIP:Young氏，夜＋MIK 500 ml/30分
・一一一・ EC : Young氏液＋modifiedMIK 500ml/30分
。一一一oL/P: Young氏濠＋modifiedMIK 500ml/30分
・一一・ EC : Young氏液＋GIK500ml/30分
。一一oし／P:Youn g氏液＋GIK500ml/30分
・一一・ EC : Young民濠＋MK500m1/30分
L/P 
500 
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Reperfus1on 
図6 低温（心筋温 15°Cl大動脈遮断180分後血流再聞による心筋 fL/P],ECの変動
各種心筋保護法の実験的，臨床的検討




















Ao. Occlusion Reperfus1on 
(180mm) 
iいん jy~
Young Solut，。n+MIK500ml/30mrn. (Myocard. Temp. 15'C) 
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i¥I. K. 30才 AR & :¥IR （人YR.:¥!¥'RI冠漉流時間 96分















*l GR: K,3CsH50;・H20=324.42 
本2CR: l¥I宮討＜l,・7H20 =246.48 
*3 GR: '¥'nHCOo = 84.02 
本4GR: >iaCI = 58.44 
pl! 7.4 











































































λ ’Jた~ ＇ ： ＇＂ ＇！ザ；－－. , . _ 
図14 Young Solution+MIK 500ml/60分（心筋楓15℃）
LL 50才 AR (AYR）大動脈遮断時間 81分
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図15 Young Solution+modr五ed¥IIK 500 ml/60分（心筋温 15'C)
T. K. 46才 AR (AVR）大助！旅遮断時間89分





























表4 低温（心筋温 l5°C）大動脈遮断180分間における EnergyCharge 
(Control: Young氏液＋GIK500ml/30分グループ）
(1) Young氏液＋CllIK500ml/30分




o. 910 ! 
0. 910 I 
0. 910 ! 
0.910 
0. 910 ! 
0. 899 i 
o. 892 I 
0.898 I 。899I 







0. 881 . 0. 878 
0. 882 0. 880 
0. 878 o. 870 











mean I 0. 896 I 0. 880 0. 875 0. 870 0. 861 I 0. 840 
1±0. 00381土0.0049 ±0. 0044土o.0058 ±0. 00871土0.0109































































































































































































































































































表5 低温（心筋温 15°C）大動脈遮断180分後，血流再開心蘇生時の EnergyCharge 
(Control: Young氏液＋GIK500ml/30分クルー フ。）
(1) Young氏液＋MIK500ml/30分 (2) Young氏液＋modi品edMIK 500 ml/30分




















S叫 le [ EC 
i I 仏間
2 I O. 856 
3 I 0. 834 
(4) Young氏液＋GIK500ml/30分
Sample ' EC 
S.D 
p 




表7 低温（心筋温 15°C）大動脈遮断180分後，血流再関心蘇生時の Lactate/Py叩 vate比
(Control : Young氏液＋GIK500ml/30分グループ）
(1) Young氏液＋MIK500ml/30分 (2) Young氏液＋modi品ed:¥IIK 500 ml/30分
Sample L/P Sample L/P 
1 17 27 
2 24 2 19 
3 19 3 23 
ロlean 20 町lean 23 
S.D 土3.6 日D 土4.0
p NS p N討
(3) Young氏液＋MK500ml/30分 (4) Young氏液＋GIK500ml/30分
Sample L/P Sample L/P 
1 34 31 
2 30 2 21 
3 29 3 23 
mean 31 mean 25 





















































































































































































(2) Young氏液＋modi品ed:¥I IK 500 ml/30分
Sam州 0分
i I is 
2 ! 18 
3 1 18 
4 I 18 
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